The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Authors
Keywords
Hepatocellular carcinoma, Next-generation sequencing, Molecular targeted therapyg
Journal
Molecular Cancer
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-30
DOI
10.1186/s12943-017-0712-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1/PD-L1 expression and molecular associations in HPB malignancies.
- (2016) Kabir Mody et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
- (2016) J. J. Wheler et al. MOLECULAR CANCER THERAPEUTICS
- VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy
- (2015) M. Schwaederle et al. CANCER RESEARCH
- Intratumor Molecular and Phenotypic Diversity in Hepatocellular Carcinoma
- (2015) J.-C. Nault et al. CLINICAL CANCER RESEARCH
- Targeting Angiogenic Genes as a Therapeutic Approach for Hepatocellular Carcinoma
- (2015) Chi Wong et al. CURRENT GENE THERAPY
- Novel drugs in clinical development for hepatocellular carcinoma
- (2015) Oliver Waidmann et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Fibrolamellar Hepatocellular Carcinoma: A Rare but Distinct Type of Liver Cancer
- (2015) Jesper B. Andersen GASTROENTEROLOGY
- Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
- (2015) Cheryl M. Koh et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II study of front-line dovitinib (TKI258) versus sorafenib in patients (Pts) with advanced hepatocellular carcinoma (HCC).
- (2015) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma
- (2015) Adel H. Jebar et al. JOURNAL OF GENERAL VIROLOGY
- Liver cancer: Approaching a personalized care
- (2015) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model
- (2015) Evan Delgado et al. JOURNAL OF HEPATOLOGY
- Targeting cyclin dependent kinase 5 in hepatocellular carcinoma – A novel therapeutic approach
- (2015) Sandra M. Ehrlich et al. JOURNAL OF HEPATOLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma
- (2015) Ying Xie et al. PLoS One
- PathCards: multi-source consolidation of human biological pathways
- (2015) Frida Belinky et al. Database-The Journal of Biological Databases and Curation
- Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials
- (2015) Ishwaria M. Subbiah et al. Oncotarget
- The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
- (2015) Gaetano Bertino et al. Biomed Research International
- Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study
- (2015) Roula Tahtouh et al. PLoS One
- MiR-191 Regulates Primary Human Fibroblast Proliferation and Directly Targets Multiple Oncogenes
- (2015) Damon Polioudakis et al. PLoS One
- ARID2: A new tumor suppressor gene in hepatocellular carcinoma
- (2015) Hong Zhao et al. Oncotarget
- P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy
- (2015) Rabih Said et al. Oncotarget
- Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
- (2015) Eleftherios P. Samartzis et al. Oncotarget
- Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing
- (2015) Filip Janku et al. Oncotarget
- The Changing Landscape of Hepatocellular Carcinoma
- (2014) Erik S. Knudsen et al. AMERICAN JOURNAL OF PATHOLOGY
- Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2
- (2014) Yun-Han Lee et al. CANCER RESEARCH
- A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral -Secretase Inhibitor PF-03084014
- (2014) W. A. Messersmith et al. CLINICAL CANCER RESEARCH
- Genomic portrait of resectable hepatocellular carcinomas: Implications ofRB1andFGF19aberrations for patient stratification
- (2014) Sung-Min Ahn et al. HEPATOLOGY
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- Review of angiogenesis in hepatocellular carcinoma
- (2014) Jun Muto et al. HEPATOLOGY RESEARCH
- Identification of Drivers from Cancer Genome Diversity in Hepatocellular Carcinoma
- (2014) Atsushi Takai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells
- (2014) Tomomi Kogiso et al. PLoS One
- Integrated Analysis of Mutation Data from Various Sources Identifies Key Genes and Signaling Pathways in Hepatocellular Carcinoma
- (2014) Yuannv Zhang et al. PLoS One
- Hepatitis B virus infection and intrahepatic cholangiocarcinoma
- (2014) Hua-Bang Zhou WORLD JOURNAL OF GASTROENTEROLOGY
- Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations
- (2013) Han Kiat Ho et al. DRUG DISCOVERY TODAY
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- Alterations of epigenetics and microRNA in hepatocellular carcinoma
- (2013) Yoshimasa Saito et al. HEPATOLOGY RESEARCH
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Alterations of Axis Inhibition Protein 1 (AXIN1) in Hepatitis B Virus-Related Hepatocellular Carcinoma and Overexpression of AXIN1 Induces Apoptosis in Hepatocellular Cancer Cells
- (2013) Jiequn Li et al. ONCOLOGY RESEARCH
- Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies
- (2013) Cristina Della Corte WORLD JOURNAL OF GASTROENTEROLOGY
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
- (2012) A. Lachenmayer et al. CLINICAL CANCER RESEARCH
- Next-Generation Sequencing: Path for Driver Discovery in Hepatocellular Carcinoma
- (2012) S. Toffanin et al. GASTROENTEROLOGY
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
- (2012) Akihiro Fujimoto et al. NATURE GENETICS
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- Immunotherapy of hepatocellular carcinoma
- (2012) Angela D. Pardee et al. OncoImmunology
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Sorafenib: activity and clinical application in patients with hepatocellular carcinoma
- (2011) Yong-Song Guan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
- (2011) Eishiro Mizukoshi et al. HEPATOLOGY
- Fibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors
- (2011) Stephen Ward et al. SEMINARS IN LIVER DISEASE
- Clonality andTP53Mutation Analysis of Focal Nodular Hyperplasia of the Liver
- (2010) Suqin Zheng et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Sorafenib: Where do we go from here?
- (2010) Abby B. Siegel et al. HEPATOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein Dishevelled
- (2009) Ho-Jin Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy
- (2009) Doriane Gouas et al. CANCER LETTERS
- Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis
- (2009) P. Kaposi-Novak et al. CANCER RESEARCH
- Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology
- (2009) Paulette Bioulac-Sage et al. LIVER INTERNATIONAL
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
- (2008) Luca Di Tommaso et al. JOURNAL OF HEPATOLOGY
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1
- (2008) Sascha Beneke et al. NUCLEIC ACIDS RESEARCH
- DNA methylation in hepatocellular carcinoma
- (2008) Iris Tischoff WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started